Evaluating an exercise intervention to treat depression in young people

ISRCTN ISRCTN66452702
DOI https://doi.org/10.1186/ISRCTN66452702
IRAS number 276093
Secondary identifying numbers CPMS 44795, IRAS 276093
Submission date
27/03/2020
Registration date
09/04/2020
Last edited
17/10/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Depression in young people is a serious problem that can lead to lifelong poor mental health and stigma. Depression is reported in around 20% of under 18s, and over half continue to be depressed into adulthood. Problems include difficulties at home and school, maintaining friendships and taking part in social activities, including exercise. Young people with depression often delay seeking psychological support. Antidepressants can help, but they have negative side effects. Research shows that adults with depression benefit from exercise, but it is not known whether exercise is helpful for young people who are depressed. The aim of this study is to find out whether exercise is an effective treatment for young people with depression and whether it is good value for money for the NHS.

Who can participate?
Young people, aged 13-17, diagnosed with depression, from Child & Adolescent Mental Health Services (CAMHS) and GP practices.

What does the study involve?
The young people will continue to receive their usual health care and will be allocated randomly to one of three groups:
1. High-intensity exercise, through vigorous activities (e.g. football, dance)
2. Low-intensity exercise, through moderate activities (e.g. walking football/netball)
3. A control group of social non-exercise based activities (playing games, watching films)
Participants will attend two 60-minute sessions per week for 12 weeks. All groups will receive behaviour change education and support. Sessions will be delivered by Registered Exercise Professionals (REPs) supported by Mental Health Support Workers (MHSWs) at local sports and community centres. Researchers will collect information from participants at the start, and at 14 and 26 weeks. This will include questionnaires on depression, quality of life, self-esteem, service use, session attendance and changes in physical activity. The researchers will ask some participants, parents/carers, REPs and MHSWs about their experience in the study.

What are the possible benefits and risks of participating?
Taking part in the groups may lead to an improvement in low mood or depression. It is hoped that the information from this phase of the study will help to determine if a larger trial is possible. In the long-term, this might show that the READY exercise groups are helpful for young people with depression. This may mean that young people can be offered an exercise group as an alternative to drug treatment or talk therapy for treating depression. It’s difficult for some people to discuss personal things. If participants get upset whilst taking part, the researchers will stay with them until they feel better and make sure they know where to go for support if they need it. The exercises are safe for most young people, but they should not take part if they have been told by a doctor not to exercise. With any exercise programme there is a small risk of minor injuries e.g. pulled muscles or sprains. More serious injuries that can be associated with exercising e.g. fractures or ligament damage, are very rare.

Where is the study run from?
The study is sponsored by the University of Hertfordshire and will be run at three sites in Norfolk, Hertfordshire and Bedfordshire in collaboration with Active Sports Partnerships (UK)

When is the study starting and how long is it expected to run for?
June 2016 to August 2022

Who is funding the study?
NIHR Health Technology Assessment (HTA) Programme (UK)

Who is the main contact?
1. Dr Daksha Trivedi
d.trivedi@herts.ac.uk
2. Dr David Wellsted
d.m.wellsted@herts.ac.uk

Study website

Contact information

Ms Megan Smith
Public

University of Hertfordshire
College Lane
Hatfield
AL10 9AB
United Kingdom

Phone +44 (0)1707 286472
Email m.smith25@herts.ac.uk
Dr Daksha Trivedi
Scientific

University of Hertfordshire
College Lane
Hatfield
AL10 9AB
United Kingdom

ORCiD logoORCID ID 0000-0002-7572-4113
Phone +44 (0)1707285990
Email d.trivedi@herts.ac.uk
Dr David Wellsted
Scientific

University of Hertfordshire
College Lane
Hatfield
AL10 9AB
United Kingdom

ORCiD logoORCID ID 0000-0002-2895-7838
Phone +44 (0)1707286291
Email d.m.wellsted@herts.ac.uk

Study information

Study designRandomised; Both; Design type: Treatment, Psychological & Behavioural, Qualitative
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleThe clinical and cost-effectiveness of an exercise intervention for depression in adolescents: a phased, multi-site randomised controlled trial
Study acronymREADY
Study hypothesisThe aim of this feasibility study is to ascertain whether a full-scale definitive study is feasible. The objectives are to:
1. Finalise the development of the intervention and control, including the Education Component (with Behaviour Change Techniques)
2. Finalise the development of intervention training programmes for staff
3. Examine the feasibility of delivering the intervention across three sites (Hertfordshire, Norfolk and Bedfordshire)
4. Establish the potential adherence and engagement to the intervention by young people
5. Establish potential reach and representativeness
6. Examine the feasibility of delivering a randomised trial at scale
The findings will be used to refine the intervention and study delivery for a full-scale trial.
Ethics approval(s)Approved 15/04/2020, East of England - Cambridgeshire and Hertfordshire Research Ethics Committee (The Old Chapel, Royal Standard Place, Nottingham, NG1 6FS, UK; +44 (0)20 7104 8096; cambsandherts.rec@hra.nhs.uk), REC ref: 20/EE/0047
ConditionDepression
InterventionThe young people will continue to receive their usual health care. Those suitable for exercise will be allocated randomly to one of three groups:
1. High-intensity exercise, through vigorous activities (e.g. football, dance)
2. Low-intensity exercise, through moderate activities (e.g. walking football/netball)
3. A control of social non-exercise based activities (playing games, watching films)

Participants will attend two 60-minute sessions per week for 12 weeks. All groups will receive behaviour change education and support. Sessions will be delivered by Registered Exercise Professionals (REPs) supported by Mental Health Support Workers (MHSWs) at local sports and community centres. Researchers will collect information from participants at the start, and at 14 and 26 weeks. This will include questionnaires on depression, quality of life, self-esteem, service use, session attendance and changes in physical activity. We will ask some participants, parents/carers, REPs and MHSWs about their experience in the study.
Intervention typeBehavioural
Primary outcome measureAs a feasibility study, there is no primary outcome. For the future main trial, the primary outcome will be depression measured using the Child Depression Inventory (2nd Edition) score, most likely at 4 months from baseline. For the feasibility study, the outcomes are listed as follows:
1. Referral rate recorded as the number of people referred for screening via any route by the end of recruitment
2. Recruitment rate recorded as the number of eligible participants who consent to participate in the study by the end of recruitment
3. Attrition rate recorded as the number of participants who consent to participate that remain in the study until the end of follow-up at 26 weeks post randomisation
4. Attendance rate at the intervention sessions as a proportion of the total number of sessions by 12 weeks
5. Heart rate as measured using a heart rate monitor at each exercise session up to 12 weeks
6. Physical activity measured using an accelerometer as proportion of time active at baseline, 14 weeks and 26 weeks post randomisation
7. Adherence to the intervention protocol as captured by the intervention logs and rated against the adherence checklist by members of the study team at weekly intervention sessions up to 12 weeks and at 14 and 26 weeks post randomisation
8. Proportion of missing data will be reported as the percentage of recorded outcomes against those expected after account for withdrawal for each outcome separately at the end of follow-up at 26 weeks post randomisation
9. Adverse event rate recorded as the frequency, type (injury or clinical progression of depression) and severity of event by treatment arm at the end of follow-up at 26 weeks post randomisation
10. Estimate of resource use as measured through observation and study-specific questionnaire at the end of the follow-up at 26 weeks post randomisation
11. Reach and representativeness measured by the proportions of patients who are screened for participation and are randomised in comparison to the characteristics of local populations by the end of recruitment
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date01/06/2016
Overall study end date24/08/2022

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit13 Years
Upper age limit17 Years
SexBoth
Target number of participantsPlanned Sample Size: 81; UK Sample Size: 81
Total final enrolment15
Participant inclusion criteriaIn order to be as inclusive as possible, any young person meeting the inclusion criteria for low mood or depression should be considered for the study. Low mood or depression does not need to be the primary diagnosis and comorbid conditions that do not preclude exercise should not be a barrier to inclusion.

1. Help-seeking adolescents aged 13-17 years with a CDI 2 score between 17 and 36, inclusive (mild to moderate symptoms)
2. Current treatment with antidepressants or other drug, or psychological therapy is allowed
3. Young person understands their role in the trial and is able to complete trial activities
4. Young person consent to participate, with consent from parent/carer for under 16s and consent of parent/carer to provide data
5. Parent/carer/guardian also taking part in the study
6. Young person and parent/carer is able to complete the questionnaires in English
7. Young person able to get to the site where the intervention will be held
Participant exclusion criteria1. Considered unsuitable by the clinician screening for eligibility
2. Current treatment, or co-morbid conditions present contraindications to engaging in RCT or exercise
3. Active psychosis, significant substance abuse, self-harm, or suicidal ideation presenting significant risk (assessed as part of the DAWBA)
Recruitment start date06/10/2020
Recruitment end date31/12/2021

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centres

Norfolk and Suffolk NHS Foundation Trust
Hellesdon Hospital
Drayton High Road
Norwich
NR6 5BE
United Kingdom
Hertfordshire Partnership University NHS Foundation Trust
99 Waverley Road
St Albans
AL3 5TL
United Kingdom
NIHR CRN: Eastern
-
NR1 1QQ
United Kingdom
NIHR CRN: North Thames
-
W1T 7HA
United Kingdom
East London NHS Foundation Trust
CAMHS Dunstable
Beech Close Resource Centre
Beech Close
Dunstable
LU6 3SD
United Kingdom

Sponsor information

University of Hertfordshire
University/education

c/o Mrs Ellie Hubbard
University of Hertfordshire
College Lane
Hatfield
AL10 9AB
England
United Kingdom

Phone +44 (0)1707284983
Email research-sponsorship@herts.ac.uk
Website http://www.herts.ac.uk/
ROR logo "ROR" https://ror.org/0267vjk41

Funders

Funder type

Government

NIHR Evaluation, Trials and Studies Co-ordinating Centre (NETSCC); Grant Codes: 17/78/10

No information available

Results and Publications

Intention to publish date31/10/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryStored in publicly available repository
Publication and dissemination planThe main study findings will be published in a peer-reviewed, open-access journal within one year of the end of the trial.
IPD sharing planAnonymised data (CSV file format) will be stored in the University of Hertfordshire Research Archive which is publicly available. The data will be available at the end of the study as defined in the protocol. Consent will have been obtained for data purposes. There are no ethical or legal restrictions. Requests for access to the data can be emailed to the scientific contacts.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol file version v1.0 16/01/2020 09/04/2020 No No
Protocol file version 3.0 27/05/2021 02/12/2022 No No
Statistical Analysis Plan version 1.0 12/07/2022 05/12/2022 No No
HRA research summary 28/06/2023 No No
Basic results 17/10/2023 No No

Additional files

ISRCTN66452702_PROTOCOL_16Jan20_v1.0.pdf
Uploaded 09/04/2020
ISRCTN66452702_PROTOCOL_V3.0_27May21.pdf
ISRCTN66452702_SAP_v1.0_12Jul2022.pdf
ISRCTN66452702_BasicResults.pdf

Editorial Notes

17/09/2023: The basic results were uploaded.
11/09/2023: The intention to publish date was changed from 31/07/2023 to 31/10/2023.
13/03/2023: The intention to publish date was changed from 31/03/2023 to 31/07/2023. Total final enrolment added.
05/12/2022: SAP file uploaded.
02/12/2022: The following changes were made to the trial record:
1. Uploaded protocol (not peer reviewed).
2. The overall trial end date was changed from 31/08/2022 to 24/08/2022.
3. The intention to publish date was changed from 31/12/2022 to 31/03/2023.
15/07/2022: The overall trial end date has been changed from 31/07/2022 to 31/08/2022 and the plain English summary updated accordingly.
15/06/2022: The primary contact was changed.
14/06/2022: The following changes were made to the trial record:
1. The overall end date was changed from 30/06/2022 to 31/07/2022.
2. The plain English summary was updated to reflect these changes.
01/11/2021: The following changes were made to the trial record:
1. The recruitment end date was changed from 30/06/2021 to 31/12/2021.
2. The overall end date was changed from 31/12/2021 to 30/06/2022.
3. The intention to publish date was changed from 31/05/2022 to 31/12/2022.
4. The plain English summary was updated to reflect these changes.
24/03/2021: The following changes were made to the trial record:
1. The overall end date was changed from 30/09/2021 to 31/12/2021.
2. The recruitment end date was changed from 31/03/2021 to 30/06/2021.
3. The plain English summary was updated to reflect these changes.
04/01/2021: The following changes were made to the trial record:
1. The recruitment end date was changed from 31/01/2021 to 31/03/2021.
2. The overall trial end date was changed from 30/07/2021 to 30/09/2021.
05/11/2020: The following changes were made to the trial record:
1. The recruitment end date was changed from 30/11/2020 to 31/01/2021.
2. The overall trial end date was changed from 31/05/2021 to 30/07/2021.
3. Trial website added.
23/10/2020: The recruitment start date was changed from 14/09/2020 to 06/10/2020.
24/08/2020: The following changes have been made:
1. The recruitment start date has been changed from 01/08/2020 to 14/09/2020.
2. The ethics approval information has been updated with the date of approval.
09/04/2020: Uploaded protocol Version 1.0, 16 January 2020 (not peer reviewed).
30/03/2020: Trial's existence confirmed by the NIHR.